| Date Filed | Type | Description |
| 08/04/2023 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 60,000 options to buy
@ $1.13, valued at
$67.8k
|
|
| 01/27/2023 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 50,000 options to buy
@ $0.79, valued at
$39.5k
|
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2022 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Sold 20,000 shares
@ $15.34, valued at
$306.8k
|
|
| 02/16/2022 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 12,000 restricted stock units
@ $0 |
|
| 01/11/2022 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 40,000 options to buy
@ $2.53, valued at
$101.2k
|
|
| 01/06/2022 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 50,000 options to buy
@ $3.35, valued at
$167.5k
|
|
| 12/30/2021 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $7.07, valued at
$141.4k
|
|
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 1,333 restricted stock units
@ $0 |
|
| 12/04/2019 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 33,500 options to buy
@ $4.64, valued at
$155.4k
Granted 4,000 restricted stock units
@ $0 |
|
| 12/28/2018 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Bought 25,000 shares
@ $1.91, valued at
$47.8k
|
|
| 12/21/2018 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 25,000 options to buy
@ $2.24, valued at
$56k
|
|
| 12/17/2018 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Bought 60,000 shares
@ $2.48, valued at
$148.8k
|
|
| 06/11/2018 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Bought 20,000 shares
@ $3.41, valued at
$68.2k
|
|
| 05/31/2018 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Bought 20,000 shares
@ $3.75, valued at
$75k
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2017 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 30,000 options to buy
@ $1.13, valued at
$33.9k
|
|
| 06/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/07/2016 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Bought 25,000 shares
@ $2.03, valued at
$50.8k
|
|
| 01/04/2016 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $2.53, valued at
$50.6k
|
|
| 04/30/2015 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.|
Txns:
| Bought 5,000 shares
@ $3.25, valued at
$16.3k
|
|
| 04/28/2015 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.|
Txns:
| Bought 15,000 shares
@ $3.71, valued at
$55.7k
|
|
| 03/30/2015 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.|
Txns:
| Bought 5,000 shares
@ $4.17, valued at
$20.9k
|
|
| 08/27/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/21/2009 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on NOVEN PHARMACEUTICALS INC |
| 05/27/2009 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on NOVEN PHARMACEUTICALS INC |